UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000042107
Receipt No. R000048053
Scientific Title Effects of denosumab on the treatment of osteoporosis and inhibition of bone erosion in rheumatoid arthritis
Date of disclosure of the study information 2020/10/14
Last modified on 2021/10/15 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effects of denosumab on the treatment of osteoporosis and inhibition of bone erosion in rheumatoid arthritis
Acronym Evaluation of the Therapeutic Effect of Denosumab on Rheumatoid Arthritis and Osteoporosis
Scientific Title Effects of denosumab on the treatment of osteoporosis and inhibition of bone erosion in rheumatoid arthritis
Scientific Title:Acronym Evaluation of the Therapeutic Effect of Denosumab on Rheumatoid Arthritis and Osteoporosis
Region
Japan

Condition
Condition Rheumatoid Arthritis
Classification by specialty
Clinical immunology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of denosumab in treating osteoporosis and inhibiting bone erosion in rheumatoid arthritis cases.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Evaluation of Bone Mineral Density at week 52
Key secondary outcomes Evaluation of Bone Erosion at week 52

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Meet the diagnosis of rheumatoid arthritis and osteoporosis
Key exclusion criteria Use of parathyroid hormones drugs
History of bone metabolic disease
hypocalcemia
Target sample size 200

Research contact person
Name of lead principal investigator
1st name Yu
Middle name
Last name Mori
Organization Tohoku University Graduate School of Medicine
Division name Orthopedic Surgery
Zip code 9808574
Address 1-1 Seiryo-machi, Aoba-ku, Sendai
TEL 0227177245
Email yu-mori@med.tohoku.ac.jp

Public contact
Name of contact person
1st name Yu
Middle name
Last name Mori
Organization Tohoku University Graduate School of Medicine
Division name Orthopedic Surgery
Zip code 9808574
Address 1-1 Seiryo-machi, Aoba-ku, Sendai
TEL 0227177245
Homepage URL
Email yu-mori@med.tohoku.ac.jp

Sponsor
Institute Department of Orthopedic Surgery, Tohoku University Graduate School of Medicine
Institute
Department

Funding Source
Organization self funding
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tohoku University Graduate School of Medicine Ethics Committee
Address 2-1 Seiryo-machi, Aoba-ku, Sendai
Tel 0227178007
Email med-kenkyo@grp.tohoku.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 10 Month 14 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 10 Month 12 Day
Date of IRB
2020 Year 12 Month 24 Day
Anticipated trial start date
2021 Year 01 Month 01 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information N/A

Management information
Registered date
2020 Year 10 Month 14 Day
Last modified on
2021 Year 10 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000048053